Editorially curated · sa-covid-national-genomic-surveillance
COVID-19 National Genomic Surveillance Program
Sequences and tracks SARS-CoV-2 lineages and emerging variants within Saudi Arabia's integrated respiratory surveillance architecture.
01 / Project overview
What the record establishes.
- Geographic scope
- Nationwide Saudi SARS-CoV-2 surveillance linked to IISS
- Project type
- National pathogen-genomic surveillance child program
- Research domain
- SARS-CoV-2 variants and outbreak surveillance
- Years
- 2020–
- Lifecycle status
- active
- Status basis
- WHO explicitly identified the named national genomic-surveillance program as part of IISS and active variant monitoring in December 2022.
- Status evidence date
- 2022-12-13
- Scale
- No authoritative unduplicated national genome count is reported in the cited official source.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Saudi Public Health Authority / Weqaya · Saudi Ministry of Health
- Partner organizations
- Saudi Integrated Influenza Sentinel Surveillance System
- Organism / population
- SARS-CoV-2-positive respiratory specimens from Saudi Arabia
03 / Data and access
What exists and how it can be reached.
Data types
- SARS-CoV-2 whole-genome sequencing
- variant surveillance
- epidemiologic metadata
Data access
Public-health surveillance; selected sequences may be shared internationally
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Explicitly named national pathogen-genomics program in an authoritative WHO account.
Editorial note
Child/linked program of IISS. KAUST R3T and institutional sequencing cohorts likely contributed or ran in parallel, but exact sample lineage is unreported; counts must not be summed. Current status after 2022 was not independently verified.
Sources
- primary record source Verified 2026-08-15
Release v0.2.0